Esophageal cancer Treatment in Uni-asia Cancer hospital

UNI-ASIA Cancer Hospital in Chengdu, China, provides specialized care for esophageal cancer using minimally invasive techniques. Patients can access diagnostics such as online consultations for around $150 and full-body PET/CT scans for around $1,300. Treatment is led by Prof. Dr. Liao Zhengyin, a Johns Hopkins-trained expert with over 25 years of experience.

Expert oncology team

Prof. Dr. Liao Zhengyin serves as the chief physician and leads the multidisciplinary team for complex tumors. He has performed over 100,000+ procedures throughout his career. Prof. Dr. Liao Zhengyin previously worked as a senior visiting scholar at Johns Hopkins Hospital in the USA. His expertise focuses on interventional oncology and minimally invasive methods that help improve survival rates for advanced cancer cases.

Diagnostic services

The hospital uses advanced imaging to identify the stage and location of the tumor. Early detection through endoscopy at this facility contributes to a five-year survival rate of over 80% for esophageal cancer. Available diagnostic options include:

• Online consultation with oncologist. Patients can speak with a specialist remotely for around $150.
• CT scan of the whole body. This imaging helps track the spread of the disease and costs around $1,300.
• PET/CT. A detailed scan used for precise cancer staging, typically priced around $1,300.

Treatment and surgical options

The clinic features 600 beds and 80 private rooms for patients undergoing intensive therapy. A multidisciplinary team reviews each case to select the most effective path, whether curative or palliative. The hospital offers several specialized treatments:

• Endoscopic mucosal resection. This minimally invasive therapy removes early-stage lesions with very little trauma to the body.
• Self-expanding metal stent placement. Doctors place these stents endoscopically to relieve swallowing difficulties in advanced cases.
• Surgery. Surgeons perform an esophagectomy to remove localized tumors, offering curative potential for early-stage disease.
• Targeted therapy and immunotherapy. These include HER2-targeted drugs and checkpoint inhibitors to improve survival in advanced stages.
• Laser ablation and photodynamic therapy. These light-based methods help control tumor growth when surgery is not an option.
• Concurrent chemoradiotherapy. This combines radiation and chemotherapy for locally advanced disease that cannot be surgically removed.

You can request a consultation through Bookimed to learn more about the treatment plans available at this hospital.